Online first
Original article
Published online: 2024-05-09
Elevated carbonylated proteins are associated with major cardiovascular events in patients with chronic coronary syndrome: A cohort study
Pubmed: 38767160
Abstract
Not available
References
- Zhang Y, Murugesan P, Huang K, et al. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets. Nat Rev Cardiol. 2020; 17(3): 170–194.
- Loffredo L, Ivanov V, Ciobanu N, et al. Low-grade endotoxemia and NOX2 in patients with coronary microvascular angina. Kardiol Pol. 2022; 80(9): 911–918.
- Akagawa M. Protein carbonylation: molecular mechanisms, biological implications, and analytical approaches. Free Radic Res. 2021; 55(4): 307–320.
- Domínguez-González M, Puigpinós M, Jové M, et al. Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging. Exp Gerontol. 2018; 111: 218–228.
- Bagyura Z, Takács A, Kiss L, et al. Level of advanced oxidation protein products is associated with subclinical atherosclerosis. BMC Cardiovasc Disord. 2022; 22(1): 5.
- Becatti M, Marcucci R, Bruschi G, et al. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arterioscler Thromb Vasc Biol. 2014; 34(7): 1355–1361.
- Błaż M, Natorska J, Bembenek JP, et al. Protein carbonylation contributes to prothrombotic fibrin clot phenotype in acute ischemic stroke: Clinical associations. Stroke. 2023; 54(11): 2804–2813.
- Paszek E, Pociask E, Ząbczyk M, et al. Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients. Atherosclerosis. 2022; 346: 124–132.
- Cieslik J, Mrozinska S, Broniatowska E, et al. Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study. Blood. 2018; 131(7): 797–807.
- Jankowski P, Topór-Mądry R, Gąsior M, et al. Management and predictors of clinical events in 75 686 patients with acute myocardial infarction. Kardiol Pol. 2022; 80(4): 468–475.
- Özcan C, Deleskog A, Schjerning Olsen AM, et al. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study. Eur Heart J Cardiovasc Pharmacother. 2018; 4(1): 25–35.
- Violi F, Loffredo L, Carnevale R, et al. Atherothrombosis and oxidative stress: mechanisms and management in elderly. Antioxid Redox Signal. 2017; 27(14): 1083–1124.
- Griendling KK, Camargo LL, Rios FJ, et al. Oxidative stress and hypertension. Circ Res. 2021; 128(7): 993–1020.
- Pirinccioglu AG, Gökalp D, Pirinccioglu M, et al. Malondialdehyde (MDA) and protein carbonyl (PCO) levels as biomarkers of oxidative stress in subjects with familial hypercholesterolemia. Clin Biochem. 2010; 43(15): 1220–1224.
- Hecker M, Wagner AH. Role of protein carbonylation in diabetes. J Inherit Metab Dis. 2018; 41(1): 29–38.
- Turkiewicz S, Sochal M, Ditmer M, et al. Evaluation of oxidative stress in obstructive sleep apnea and its comorbidities using serum concentrations of oxidized guanine species. Pol Arch Intern Med. 2023; 133(9): 16542.
- Undas A. Statins in prevention of thromboembolic events: From seminal studies to recent advances. Pol Arch Intern Med. 2022; 132(2): 16208.
- Paton LN, Mocatta TJ, Richards AM, et al. Increased thrombin-induced polymerization of fibrinogen associated with high protein carbonyl levels in plasma from patients post myocardial infarction. Free Radic Biol Med. 2010; 48(2): 223–229.
- de Vries JJ, Snoek CJM, Rijken DC, et al. Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis: A systematic review. Arterioscler Thromb Vasc Biol. 2020; 40(3): 554–569.
- Suzuki Y, Tanaka H, Horinouchi T, et al. Fibrinolysis-resistant carbonylated fibrin detected in thrombi attached to the vascular wall of abdominal aortic aneurysms. Sci Rep. 2020; 10(1): 20728.
- Siudut J, Natorska J, Zabczyk M, et al. Impaired plasminogen binding in patients with venous thromboembolism: Association with protein carbonylation. Thromb Res. 2018; 163: 12–18.
- Lisman T. Decreased plasma fibrinolytic potential as a risk for venous and arterial thrombosis. Semin Thromb Hemost. 2017; 43(2): 178–184.
- Petry A, BelAiba RS, Weitnauer M, et al. Inhibition of endothelial nitric oxyde synthase increases capillary formation via Rac1-dependent induction of hypoxia-inducible factor-1α and plasminogen activator inhibitor-1. Thromb Haemost. 2012; 108(5): 849–862.
- Draxler D, Sashindranath M, Medcalf R. Plasmin: A modulator of immune function. Semin Thromb Hemost. 2016; 43(02): 143–153.
- Zhao L, Morser J, Bajzar L, et al. Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms. Thromb Haemost. 1998; 80(6): 949–955.
